The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver
Open accessAbstract
The liver is an important integrator of nutrient metabolism, yet no liver-derived factors regulating nutrient preference or carbohydrate appetite have been identified. Here we show that the liver regulates carbohydrate intake through production of the hepatokine fibroblast growth factor 21 (FGF21), which markedly suppresses consumption of simple sugars, but not complex carbohydrates, proteins, or lipids. Genetic loss of FGF21 in mice increases sucrose consumption, whereas acute administration or overexpression of FGF21 suppresses the intake of both sugar and non-caloric sweeteners. FGF21 does not affect chorda tympani nerve responses to sweet tastants, instead reducing sweet-seeking behavior and meal size via neurons in the hypothalamus. This liver-to-brain hormonal axis likely represents a negative feedback loop as hepatic FGF21 production is elevated by sucrose ingestion. We conclude that the liver functions to regulate macronutrient-specific intake by producing an endocrine satiety signal that acts centrally to suppress the intake of "sweets."
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, increased levels of the hepatokine FGF21, although not influencing appetite per se, have been linked to decreased intake of obesogenic sugary foods [168] (5).”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [168]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, a recent study suggests that FGF21 may be involved in regulating preference for specific foods; specifically, it acts to reduce craving for sugary foods [168].”
In the citing paper
“Hepatic mRNA and plasma protein levels of FGF21 are induced by high sugar intake through a mechanism dependent on the transcription factor ChREBP22–25”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“KLB expression is primarily restricted to specific metabolic tissues (for example, the liver, pancreas and adipose tissue)5, and lower expression is observed in the brain22,48–50. Despite some reports to the contrary51,52, KLB is not expressed in muscle5,41.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“mice lacking FGF21 also exhibit a greater preference for sucrose22.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“FGF21 is induced by simple-sugar intake in both mice and humans22,32,33, and that sugar-induced production of FGF21 from the liver occurs in a ChREBP-dependent manner22,121.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“FGF21 signals to the CNS and consequently suppresses simple-sugar intake and sweet-taste preference22,122, but not protein or lipid intake22,84.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“Thus, increased FGF21 production from the liver in response to carbohydrate intake is a negative feedback loop regulating carbohydrate intake22.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“While physiological FGF21 signalling to glutamatergic neurons in the paraventricular nucleus regulates basal sucrose intake22,48, FGF21 signalling to glutamatergic neurons in the ventromedial hypothalamus (VMH) is required for FGF21-mediated suppression of simple-sugar intake48.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [22]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [137]
In the citing paper
“Excess simple sugar intake increases plasma FGF21 levels in humans and rodents [137,138].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [137]
In the citing paper
“FGF21 also regulates macronutrient-specific intake and sweet-taste preference in response to the activation of the hepatic glucose-sensitive transcription factor, carbohydrate responsive element-binding protein (ChREBP) [137].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [137]
In the citing paper
“In addition, in humans, plasma FGF21 levels have been shown to be induced by increases in both glucose and insulin levels (31, 84, 110, 133), supporting a role during refeeding.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Consistent with these data in humans, Fgf21 total knockout mice exhibit an increased preference for simple sugars, but not lipids or protein (133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Indeed, the administration of recombinant FGF21 to mice markedly reduces carbohydrate preference without affecting the preferences for lipid and protein (133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Interestingly, FGF21 also suppresses the intake of noncaloric sweeteners (125, 133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Importantly, loss of β-klotho in the PVN of the hypothalamus, but not the suprachiasmatic nucleus, impaired FGF21-mediated suppression of sucrose intake (133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Mice lacking ChREBP fail to show an increase in plasma FGF21 levels in response to simple sugar intake (35, 133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Ad libitum feeding of sucrose for 6–24 hours gradually increases hepatic and plasma FGF21 levels in wild-type mice, and this effect is lost in liver-specific Fgf21 knockout mice (133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“FGF21 mediates these effects on simple sugar and sweet taste preference not by affecting sweet taste sensing, but rather by affecting taste processing.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [133]
In the citing paper
“Circulating FGF21 levels are robustly increased by diets that are high in carbohydrate but low in protein”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“exogenous FGF21 treatment reduces the consumption of sweet foods and alcohol while alternatively increasing the consumption of protein”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“driven at least in part by the transcription factor carbohydrate response element binding protein (ChREBP), which binds directly to the FGF21 promoter”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“Both acute carbohydrate ingestion and long-term exposure to high-carbohydrate diets significantly increase liver FGF21 mRNA expression and circulating FGF21 levels”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“liver FGF21 production seems to be robustly stimulated by an imbalance in macronutrients, particularly settings of high-carbohydrate but low-protein intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“FGF21 acts in the brain, via Klb, to suppress sweet and alcohol intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“The best evidence currently supports the hypothalamic PVN, as the deletion of Klb from the PVN blocked the effects on sweet intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“This effect of FGF21 on sweet intake was impaired when the FGF21 co-receptor Klb was deleted from the hypothalamic paraventricular nucleus (PVN).”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“these FGF21-dependent effects appeared to be specific for sweet/sugar, as there was no effect on the nonsweet carbohydrate maltodextrin”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“mice that genetically overexpressed or were treated with FGF21 reduced their consumption of a high-sucrose diet and reduced their consumption of sucrose and the noncaloric sweeteners saccharin and sucralose”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
In the citing paper
“FGF21-deficient mice increased their consumption of a solid, high-sucrose diet, as well as solutions containing sucrose, glucose, or fructose”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian sweet taste receptors
Nelson, G., Hoon, M. A., Chandrashekar, J., Zhang, Y., Ryba, N. J. P., & Zuker, C. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00451-2 · Cited by 1,702
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Johnson, R. K., Appel, L. J., Brands, M., Howard, B. V., Lefevre, M., Lustig, R. H., Sacks, F., Steffen, L. M., & Wylie-Rosett, J. (2009) · Circulation · doi:10.1161/circulationaha.109.192627 · Cited by 1,207
Imamura, F., O’Connor, L., Ye, Z., Mursu, J., Hayashino, Y., Bhupathiraju, S. N., & Forouhi, N. G. (2015) · BMJ · doi:10.1136/bmj.h3576 · Cited by 977 · cited 3×
“has been linked with metabolic disease (Imamura et al., 2015; Johnson et al., 2009).”
Imamura, F., O’Connor, L., Ye, Z., Mursu, J., Hayashino, Y., Bhupathiraju, S. N., & Forouhi, N. G. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-h3576rep · Cited by 968
Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401516101 · Cited by 834
Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704
Self-citationDetection of Sweet and Umami Taste in the Absence of Taste Receptor T1r3
Damak, S., Rong, M., Yasumatsu, K., Kokrashvili, Z., Varadarajan, V., Zou, S., Jiang, P., Ninomiya, Y., & Margolskee, R. F. (2003) · Science · doi:10.1126/science.1087155 · Cited by 632
FGF21 is an endocrine signal of protein restriction
Laeger, T., Henagan, T. M., Albarado, D. C., Redman, L. M., Bray, G. A., Noland, R. C., Münzberg, H., Hutson, S. M., Gettys, T. W., Schwartz, M. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74915 · Cited by 593 · cited 1×
“Interestingly, consumption of low protein diets also increases hepatic and plasma FGF21 levels in humans (Laeger et al., 2014).”
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J. (2014) · Diabetes · doi:10.2337/db14-0595 · Cited by 590
Self-citation
Flagged first, then by citations
1 of the 37 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 340
Larsson, S. C., & Gill, D. (2021) · Nutrients · doi:10.3390/nu13051504 · Cited by 17
Inter-organ insulin-leptin signal crosstalk from the liver enhances survival during food shortages
Takahashi, K., Yamada, T., Hosaka, S., Kaneko, K., Asai, Y., Munakata, Y., Seike, J., Horiuchi, T., Kodama, S., Izumi, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112415 · Cited by 17
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Richter, M. M., Kemp, I. M., Heebøll, S., Winther‐Sørensen, M., Kjeldsen, S. A. S., Jensen, N. J., Nybing, J. D., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155915 · Cited by 15
Dâmaso, A. R., Masquio, D. C. L., Campos, R. M. D. S., Corgosinho, F. C., & Cercato, C. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15251 · Cited by 15
Fgf21 regulates T-cell development in the neonatal and juvenile thymus
Nakayama, Y., Masuda, Y., Ohta, H., Tanaka, T., Washida, M., Nabeshima, Y., Miyake, A., Itoh, N., & Konishi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-00349-8 · Cited by 15
Hron, B. M., Ebbeling, C. B., Feldman, H. A., & Ludwig, D. S. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0198-y · Cited by 15
FAP finds FGF21 easy to digest
Gillum, M. P., & Potthoff, M. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160004 · Cited by 14
Self-citationThe Role of Mondo Family Transcription Factors in Nutrient-Sensing and Obesity
Ke, H., Luan, Y., Wu, S., Zhu, Y., & Tong, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653972 · Cited by 14
Janzi, S., González-Padilla, E., Najafi, K., Ramne, S., Ahlqvist, E., Borné, Y., & Sonestedt, E. (2021) · Nutrients · doi:10.3390/nu13113954 · Cited by 15
Dorval, L., Knapp, B. I., Majekodunmi, O. A., Eliseeva, S. I., & Bidlack, J. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108858 · Cited by 13
Jois, T., & Sleeman, M. W. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12473 · Cited by 14
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice
Albarazanji, K. A., Jennis, M., Cavanaugh, C., Lang, W., Singh, B., Lanter, J. C., Lenhard, J. M., & Hornby, P. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00404.2018 · Cited by 13
FGF family in health and disease
Liu, X., Jing, M., Yang, Y., Jin, Q., Feng, B., Zhang, P., Niu, C., Hu, X., & Huang, Z. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00429-0 · Cited by 14
Richter, M. M., Thomsen, M. N., Skytte, M. J., Kjeldsen, S. A. S., Samkani, A., Frystyk, J., Magkos, F., Holst, J. J., Madsbad, S., Krarup, T., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae008 · Cited by 13
Theerajangkhaphichai, W., Sripetchwandee, J., Sriwichaiin, S., Svasti, S., Chattipakorn, N., Tantiworawit, A., & Chattipakorn, S. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-87597-x · Cited by 12
Fukumura, K., Narimatsu, Y., Moriwaki, S., Ukena, K., Furumitsu, M., & Ukena, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094681 · Cited by 12
Kondeti, S., Dinesh Yadav, D. M., Muralidhar, M. N., Prasad, S. M. V. K., Nemani, H., & Kalashikam, R. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111252 · Cited by 12
Saber-Ayad, M. M., Hammoudeh, S. M., Radwan, H. M., Manzoor, S., Jabbar, H. A., Wardeh, R., Ashraf, A., Habib, P. T., Alsamman, A. M., & Hamoudi, R. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.05.020 · Cited by 11
Negroiu, C. E., Tudorașcu, I., Beznă, M. C., Ungureanu, A., Honţaru, S. O., & Dănoiu, S. (2024) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.65.2.02 · Cited by 11
Esteve, N. A., Rogers, D. J., Stagray, J. A., Mayeux, H., Nora, G., Huval, L., & Smith, K. M. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16473 · Cited by 11
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Self-citationWu, C.-T., Magaña, D. G., Roshgadol, J., Tian, L., & Ryan, K. K. (2024) · Appetite · doi:10.1016/j.appet.2024.107673 · Cited by 11
Ramne, S., García‐Ureña, M., Gillum, M. P., Ängquist, L. H., Hansen, T., Merino, J., & Grarup, N. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102049 · Cited by 11
Self-citationFibroblast growth factor 21 and dietary macronutrient intake in female mice
Wu, C.-T., Larson, K. R., Goodson, M. L., & Ryan, K. K. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113995 · Cited by 13
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11
Kim, S. Q., Spann, R. A., Khan, M. S. H., Berthoud, H., Münzberg, H., Albaugh, V. L., He, Y., McDougal, D. H., Soto, P. L., Yu, S., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110010 · Cited by 10
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
New insights into the inter-organ crosstalk mediated by ChREBP
Carbinatti, T., Régnier, M., Parlati, L., Benhamed, F., & Postic, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095440 · Cited by 13
Xie, J., Yan, J., Ji, K., Guo, Y., Xu, S., Shen, D., Li, C., Gao, H., & Zhao, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132667 · Cited by 10
ChREBP refines the hepatic response to fructose to protect the liver from injury
Hall, A. M., & Finck, B. N. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95008 · Cited by 10
Solomon, T. P. J., Carter, S., Haus, J. M., Karstoft, K., von Holstein‐Rathlou, S., Nielsen, M. S., & Gillum, M. P. (2022) · PeerJ · doi:10.7717/peerj.12755 · Cited by 10
Self-citationFGF21 negatively affects long-term female fertility in mice
Moeckli, B., Pham, T.-V., Slits, F., Latrille, S., Peloso, A., Delaune, V., Oldani, G., Lacotte, S., & Toso, C. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11490 · Cited by 9
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
She, Q.-Y., Li, L., Liu, M.-H., Tan, R.-Y., Zhong, Y.-W., Bao, J., & Xie, J.-D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011008 · Cited by 9
Insights into energy balance dysregulation from a mouse model of methylmalonic aciduria
Lucienne, M., Gerlini, R., Rathkolb, B., Calzada‐Wack, J., Forny, P., Wueest, S., Kaech, A., Traversi, F., Forny, M., Bürer, C., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad100 · Cited by 9
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
Sadowska, A., Poniedziałek‐Czajkowska, E., & Mierzyński, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417298 · Cited by 9
Parsing the Potential Neuroendocrine Actions of FGF21 in Primates
Gillum, M. P. (2018) · Endocrinology · doi:10.1210/en.2018-00208 · Cited by 9
Self-citationPsychology and Pathophysiological Outcomes of Eating
Takada, A., & Himmerich, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92917 · Cited by 10
Fukumura, K., & Nagata, S. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1343119 · Cited by 9
Yen, H., Hsieh, S., Chen, C., Yang, W., Lee, P., Lin, M., Chen, C., & Yang, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-62395-z · Cited by 9
Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice
Zhang, Y., Cochran, J. D., Souvenir, R., Tai, W. C., Xia, R., Gladwin, B. S., Barton, N. B., Pereira, R. O., & Abel, E. D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf131 · Cited by 8
Wang, W., Xin, Y.-Y., Niu, J.-Q., & Jin, W.-L. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101460 · Cited by 9
Vincenzo, A. D., Crescenzi, M., Granzotto, M., Vecchiato, M., Fioretto, P., Vettor, R., & Rossato, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02273-3 · Cited by 8
Fukumura, K., Shikano, K., Narimatsu, Y., Ukena, K., Furumitsu, M., Naito, M., & Ukena, K. (2021) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbab064 · Cited by 8
Neurosecretory Protein GL Accelerates Liver Steatosis in Mice Fed Medium-Fat/Medium-Fructose Diet
Narimatsu, Y., Ukena, K., Naito, M., Moriwaki, S., Furumitsu, M., & Ukena, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042071 · Cited by 8
The Sweetest Thing: Regulation of Macronutrient Preference by FGF21
Adams, A. C., & Gimeno, R. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.013 · Cited by 8
Nielsen, M. S., Ritz, C., Chenchar, A., Bredie, W. L. P., Gillum, M. P., & Sjödin, A. M. (2021) · Nutrients · doi:10.3390/nu13113840 · Cited by 7
Self-citationSostre‐Colón, J., Gavin, M. J., Santoleri, D., & Titchenell, P. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac035 · Cited by 7
Rama, K., Jahagirdar, V., & Sanyal, A. J. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560034 · Cited by 6
Wu, C.-T., Larson, K. R., Sims, L. C., & Ryan, K. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114368 · Cited by 7
Reho, J. J., Muskus, P. C., Bennett, D. M., Grobe, C. C., Burnett, C. M.-L., Nakagawa, P., Segar, J. L., Sigmund, C. D., & Grobe, J. L. (2024) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00273.2023 · Cited by 6
Carroll, H. A., Chen, Y., Templeman, I., James, L. J., Betts, J. A., & Trim, W. V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235557 · Cited by 6
Basolo, A., Hollstein, T., Shah, M. H., Walter, M. F., Krakoff, J. A., Votruba, S. B., & Piaggi, P. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab204 · Cited by 6
Gehring, J., Azzout‐Marniche, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Even, P. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00246.2021 · Cited by 7
FGF21 response to sucrose is associated with BMI and dorsal striatal signaling in humans
Alves, J. M., Yunker, A. G., LUO, S. H., Jann, K., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Smith, A., Monterosso, J. R., & Page, K. A. (2022) · Obesity · doi:10.1002/oby.23432 · Cited by 7
The role of FGF21 in the metabolic adjustments required for exercise capacity
Abe, L., & Dantzer, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123940 · Cited by 5
Alamgir, M., Sohal, A., & Kowdley, K. V. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560039 · Cited by 5
Wang, Z., Tang, Y., Liu, Y., Zeng, Y., & Zhang, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152042 · Cited by 5
Gijbels, A., Schutte, S., Esser, D., Michielsen, C. C. J. R., Siebelink, E., Mars, M., Mensink, M., & Afman, L. A. (2022) · Nutrients · doi:10.3390/nu14235061 · Cited by 5
Context matters for addressing controversies in FGF21 biology
Wu, C.-T., & Ryan, K. K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.013 · Cited by 5
Doridot, L., Hannou, S. A., Krawczyk, S. A., Tong, W., Kim, M.-S., McElroy, G. S., Fowler, A. J., Astapova, I. I., & Herman, M. A. (2021) · Nutrients · doi:10.3390/nu13103642 · Cited by 5
Fibroblast growth factor 21 signaling: The liver in focus
Mahlapuu, M., & Marschall, H. (2016) · Hepatology · doi:10.1002/hep.28591 · Cited by 5
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
Negative feedback regulation of alcohol ingestion through the FGF21-PVH oxytocin-VTA dopamine system
Matsui, S., Takahashi, Y., Morioka, S., Ozawa, T., Kanayama, S., Iwama, H., Geng, L., Umemoto, K., Oguri, Y., Tsuzuki, S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525172122 · Cited by 4
Spann, R. A., Kim, S. Q., Khan, M. S. H., Albarado, D. A., Fernandez‐Kim, S. O., Berthoud, H., McDougal, D. H., Münzberg, H., He, Y., Yu, S., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117218 · Cited by 4
Zheng, S., Wu, J., Xiang, S., Zang, Y., Kong, D., Wei, X., Sun, W., & Li, W. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111170 · Cited by 4
Wang, J., Beecher, K., Chehrehasa, F., & Moody, H. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0072 · Cited by 4
Genetic determinants of beverage consumption: Implications for nutrition and health
Cornelis, M. C. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.03.001 · Cited by 4
Błaszczyk, J. W. (2025) · Metabolites · doi:10.3390/metabo15060404 · Cited by 3
Dynamics of feeding behaviour and meal patterning in protein-restricted mice
Taghipourbibalan, H., & McCutcheon, J. E. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115454 · Cited by 3
Szczepańska, E., Glinicki, P., Zgliczyński, W., Slowinska-Srzednicka, J., Jastrzębska, H., & Gietka‐Czernel, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.900034 · Cited by 3
Liquid fructose and liver insulin signaling: Molecular mechanisms controlling hepatic steatosis
Sangüesa, G., Roglans, N., Laguna, J. C., & Alegret, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00004-5 · Cited by 3
Genetics of mouse behavioral and peripheral neural responses to sucrose
Lin, C., Inoue, M., Li, X., Bosak, N. P., Ishiwatari, Y., Tordoff, M. G., Beauchamp, G. K., Bachmanov, A. A., & Reed, D. R. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09858-4 · Cited by 3
Jain, U., Srivastava, P., Sharma, A., Sinha, S., & Johari, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998265915231116043813 · Cited by 3
Evaluating Fibroblast Growth Factor 21 (FGF21) Levels Post-Gastric Sleeve Surgery in Obese Patients
Al-Regaiey, K., Iqbal, M., Alzaid, M., Alkaoud, O. A., Alhadyani, M. A., Alagel, O. A., Alshehri, S. S., Altamimi, I., & Alsofayan, S. M. (2024) · Cureus · doi:10.7759/cureus.66122 · Cited by 3
FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
Klímová, J., Zelinka, T., Rosa, J., Štrauch, B., Haluzíková, D., Haluzı́k, M., Holaj, R., Krátká, Z., Kvasnička, J., Ďurovcová, V., et al. (2019) · Cancers · doi:10.3390/cancers11040485 · Cited by 3
Ramírez-Contreras, C. Y., Mehran, A. E., Salehzadeh, M., Mussai, E., Miller, J. W., Smith, A., Ranger, M., Holsti, L., Soma, K. K., & Devlin, A. M. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00091.2021 · Cited by 3
Kodama, S., Togami, W., & Miyamoto, T. K. (2022) · Transplantation Proceedings · doi:10.1016/j.transproceed.2022.08.002 · Cited by 3
Adipokines, Inflammation, and Insulin Resistance in Obesity
Kwon, H., & Pessin, J. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_9 · Cited by 3
Stevanović, D., Hebert, A. J., Desai, B. N., Singhal, G., Adams, A. C., Flier, J. S., & Maratos–Flier, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.921361 · Cited by 3
Zhang, X., Li, Z., Wang, S., & Chen, Y. (2025) · Nutrients · doi:10.3390/nu17071179 · Cited by 2
Mori, H., Inoue, K., Matsui, S., Oguri, Y., Tsuzuki, S., & Sasaki, T. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00138.2025 · Cited by 2
Janzi, S., Ramne, S., Kou, M., Lu, X., Stubbendorff, A., Ke, C., Borné, Y., Qi, L., & Sonestedt, E. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.08.020 · Cited by 2
Ramne, S., Seco, T. D. D. C., Kuentzel, K. B., Grevengoed, T. J., Hjerresen, J. P., Möritz, T., Hansen, T. F., Raben, A., & Grarup, N. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00265.2025 · Cited by 2
Lin, Y., Claflin, K. E., Aklan, İ., Morgan, D. A., Sullivan, A. I., Rudolph, M. C., Rahmouni, K., & Potthoff, M. J. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117093 · Cited by 3
Self-citationZadeh, S. S. T., Toth, P. P., & Banach, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1789019 · Cited by 2
Strober, J. W., Fernandez, S., Ye, H., & Brady, M. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00174.2021 · Cited by 2
Kang, P., Zhang, Y., Zeng, D., Liu, D., Han, R., Lu, Y.-W., Cheng, D., Wang, Q., Liu, S., Wu, L., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0390 · Cited by 2
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116582 · Cited by 2
Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N., & Söderlund, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00013-6 · Cited by 2
Metabolic Responses to Energy-Depleted Conditions
SUZUKI, T., Komatsu, T., Shibata, H., & Inagaki, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100391 · Cited by 2
Genetic controls of Tas1r3-independent sucrose consumption in mice
Lin, C., Tordoff, M. G., Li, X., Bosak, N. P., Inoue, M., Ishiwatari, Y., Chen, L., Beauchamp, G. K., Bachmanov, A. A., & Reed, D. R. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09860-w · Cited by 2
Macronutrient intake: Hormonal controls, pathological states, and methodological considerations
Przybysz, J. T., DiBrog, A. M., Kern, K. A., Mukherjee, A., Japa, J. E., Waite, M. H., & Mietlicki‐Baase, E. G. (2022) · Appetite · doi:10.1016/j.appet.2022.106365 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Efendi, O. G. H. N. B., Matsui, S., Tsukamoto, M., Oguri, Y., Tsuzuki, S., & Sasaki, T. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf147 · Cited by 1
Wali, J. A., Ramos-Nieves, J. M., Binia, A., & van der Beek, E. M. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100713 · Cited by 1
MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis
Cartee, B. S., Diniz, F., Rai, R. P., Pal, P. B., Srivastava, R., Rossmiller, D., Raeman, R., & Iyer, S. S. (2026) · Seminars in Liver Disease · doi:10.1055/a-2908-1230 · Cited by 1
FGF21 influences a 'sweet tooth' in mice
Geach, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.8 · Cited by 1
A Framework for Uncovering the Roles of Calories and Macronutrients in Health and Aging
Solon‐Biet, S. M., Wahl, D., Raubenheimer, D., Couteur, D. G. L., Simpson, S. J., & Cogger, V. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00008-7 · Cited by 1
Nutritional content and preference analysis of red dragon fruit spaghetti
Saptariana, S., & Budiono, R. (2022) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/969/1/012035 · Cited by 1
Pohlhammer, J., Heinzl, M. W., Klammer, C., Feldbauer, R., Rosenberger, K., Resl, M., Wagner, T., Obendorf, F., Egger-Salmhofer, M., Dieplinger, B., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17614 · Cited by 1
Metadata
- Authors
- von Holstein-Rathlou, S., BonDurant, L. D., Peltekian, L., Naber, M. C., Yin, T. C., Claflin, K. E., Urizar, A. I., Madsen, A. N., Ratner, C., Holst, B., Karstoft, K., Vandenbeuch, A., Anderson, C. B., Cassell, M. D., Thompson, A. P., Solomon, T. P., Rahmouni, K., Kinnamon, S. C., Pieper, A. A., Gillum, M. P., & Potthoff, M. J.
- Affiliations
- University of Iowa (US)
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- University of Colorado Anschutz (US)
- Corresponding author
- Gillum, Matthew P.
- Potthoff, Matthew J.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 23
- Issue
- 2
- Pages
- 335-343
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4756759
- OpenAlex
- W2201894846
- Cited by
- 347
- References
- 37
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 33 · 2023: 22 · 2022: 43 · 2021: 42 · 2020: 40 · 2019: 33 · 2018: 29 · 2017: 38 · 2016: 24
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF14OC0009525, NNF15SA0018486)
- National Heart, Lung, and Blood Institute (P01HL084207)
- National Institute on Deafness and Other Communication Disorders (P30DC004657)
- National Institute of General Medical Sciences (T32GM067795)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106104)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Keywords
- FGF21, hepatokines, carbohydrate intake, sucrose intake, sweet taste preference, artificial sweeteners, hypothalamic neurons, meal size, liver-brain axis, macronutrient preference, negative feedback loop
- MeSH terms
- Animals, Endocrine System, Feeding Behavior, Fibroblast Growth Factors, Food Preferences, Liver, Male, Nuclear Proteins, Sucrose, Taste, Transcription Factors, Signal Transduction, Mice, Knockout, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
